Pricing

Log inSign up

Biohaven Pharmaceuticals

6 followers

‌

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Industries

Biotechnology

Headquarters

New Haven, United States

Employees

501-1,000

Links

Org chart

VC
Vlad Coric
Chairman & CEO

Vlad Coric

Collapse
George Clark
VP, Chief Accounting Officer
Robert Croop
Chief Development Officer, Neurology
Bruce D. Car
Chief Scientific Officer
Tova Gardin
Chief Translational Officer
Matthew Buten
Chief Financial Officer
St John Donnie McGrath
Chief of Corporate Strategy & Business Development
Warren Volles
General Counsel & Chief Legal Officer
Cliff Bechtold
President & GM, Biohaven Ireland, Chief Compliance Officer
Michael Bozik
President, Ion Channel Research & Development
David Weaver
SVP, Neuroscience & Pharmacology
Kimberly Gentile
SVP, Clinical Operations
David Stock
VP, Biostatistics
Katy Mcgrath
Principal Scientist, In Vivo Science
Wes Kazmierski
Senior Director, Chemistry
Melissa Beiner
Director, R&D
Elyse Stock
Senior Scientific Advisor

Board & advisors

Michael T. Heffernan
Lead Independent Director
Gregory H. Bailey
Director
John W. Childs
Director
Robert J. Hugin
Director
Irina A. Antonijevic
Director
Gregory Hebrank
Advisor, Clinical & Discovery

Teams

+39

Leadership Team

42 members

+36

Clinical Operations Team

39 members

+26

Research and Development Team

29 members

+4

Legal and Compliance Team

7 members

Offices

Similar companies

GRAIL

27 followers

KBI Biopharma

5 followers

Veracyte

4 followers

MannKind

3 followers

Molecular Devices

2 followers

Thermo Fisher Scientific

183 followers

Gilead Sciences

139 followers

Regeneron

106 followers

Illumina

73 followers

Vertex Pharmaceuticals

67 followers

Alexion Pharmaceuticals

35 followers

Explore companies